|
Send Inquiry
08045802327Contact Us For Help
Daclatasvir Dihydrochloride tablets 60mg
30.12 USD ($)/Box
Product Details:
- Drug Type Other Types
- Dosage As Directed By Physician.
- Dosage Guidelines As Directed By Physician.
- Storage Instructions Store in a cool and dark place.
- Click to View more
X
Daclatasvir Dihydrochloride tablets 60mg Price And Quantity
- 30.12 USD ($)/Box
- 1000 Box
Daclatasvir Dihydrochloride tablets 60mg Product Specifications
- As Directed By Physician.
- Store in a cool and dark place.
- As Directed By Physician.
- Other Types
Daclatasvir Dihydrochloride tablets 60mg Trade Information
- Hazira / Nhava Sheva
- Telegraphic Transfer (T/T) Cash in Advance (CID) Cash Advance (CA)
- 1000000 Box Per Month
- 1-2 Week
- Yes
- If order is confirmed we will reimburse the sample cost
- Australia North America South America Eastern Europe Western Europe Middle East Africa Asia Central America
- WHO-GMP/ GMP/ COA/ As Required By Client
Product Description
We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of Mydacla 60mg (Daclatasvir 60mg )Tablets in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
COMPOSITION :
Mydacla 60mg (Daclatasvir 60mg )Tablets
- Brand name: Mydacla
- Active Ingredients(Generic Name) : Daclatasvir 60mg
- Company Name: Mylan Pharmaceuticals
- Strength : 60mg
- Package: 28 tabs
- Pack Type: Bottle
Indication:
Mydacla 60mg (Daclatasvir 60mg )Tablets is an inhibitor of non-structural protein 5A (NS5A). Each film-coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg. Daclatasvir is white to yellow color solid and freely soluble in water. Daclatasvir is prescribed for the treatment of patients with chronic HCV genotype 3 infections along with Sofosbuvir 400mg tablets. Daclatasvir has revolutionized the management of HEPATITIS C by offering Ribavirin and Peg-free treatment for all the genotypes of Hepatitis C.
Uses:-Mydacla 60mg (Daclatasvir 60mg )Tablets are indicated for use, with sofosbuvir, for the treatment of patients with chronic HCV genotype 3. For patients, without cirrhosis, the recommended treatment course is 12 weeks. For patients with cirrhosis, the optimal dosing duration of therapy is not known. Use of daclatasvir is contraindicated for use with drugs that are strong inducers of CYP3A
Available other Brand : Natdac ,Hepcfix ,Daclacure ,Declahep
We are manufacture and export of our brand. We also offer private labeling, Contract manufacturing service.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Hepatitis C Medicine' category
Contact Details
- 1st FLOOR, OFFICE - 102, SHUBH SQUARE, PATEL WADI - 3, OPP. SHIVANJALI ROW HOUSE, Lal Darwaja, Surat - 395004, Gujarat, India
- Corp. office :
#803, Shubh Square,Patelwadi-3, Near Lal Darwaja,Surat - 395004 (Gujarat) India. -
Send Inquiry
Send Inquiry
- Phone :08045802327
- Mr Viral Dhaduk (Director)
- Mobile :08045802327
Send Inquiry
Send SMS
Call Me Free
 |
SALVAVIDAS PHARMACEUTICAL PVT. LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |
